承董事會命 中信建投証券股份有限公司 董事長 劉 成 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6066） 海外監管公告 本 公 告 乃 中 信 建 投 証 券 股 份 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有 限公司證券上市規則第13.10B條 而 作 出。 茲 載 列 本 公 司 於 上 海 證 券 交 易 所 網 站 刊 發 之《中 信 建 投 証 券 股 份 有 限 公 司2025年 面 向 專 業 投 資 者 公 開 發 行 短 期 公 司 債 券（第 一 期）發 行 結 果 公 告》，僅 供 參 閱。 中國北京 2025年5月22日 於 本 公 告 日 期，本 公 司 執 行 董 事 為 劉 成 先 生 及 金 劍 華 先 生；本 公 司 非 執 行 董 事 為 李 岷 先 生、閆 小 ...

根据合并数据显示，多头前三席位为中信期货，总持仓38316、乾坤期货，总持仓25019、国泰君安，总持仓23071；空头前三席位 为东证期货，总持仓32995、国泰君安，总持仓29487、中信期货，总持仓23676； 主力合约前20席位中，多头增仓前三名分别是：一德期货、持仓19422、增仓2913，中泰期货、持仓5310、增仓273，中信建投、 持仓6395、增仓253；多头减仓前三名分别是：中信期货、持仓13547、减仓-3755，华泰期货、持仓2286、减仓-935，国泰君安、 持仓13868、减仓-851； 新浪期货 根据交易所数据，截至5月22日收盘主力合约豆一2507,涨跌-0.29%,成交量12.30万手，持仓数据显示前20席位呈现净空， 差额头寸为3117手。 豆一期货全合约总计成交19.53万手，比上一日减少8.81万手。全合约前20席位多头持仓23.55万手，比上一日减少1611手。全合约 前20席位空头持仓25.10万手，比上一日增加284手。 | | | | | 2025年5月22日豆一全合约持仓数据一览 | | | | | | | --- | --- | --- | --- | -- ...

Core Viewpoint - The company, BOE Technology Group, is optimistic about the LCD industry, highlighting a shift towards "demand-driven production" and a healthy market recovery in mainland China, which is expected to mitigate uncertainties from international trade dynamics [1][2]. Industry Supply and Demand - The LCD industry is transitioning to a "demand-driven production" strategy, with manufacturers adjusting production rates based on market needs. This has led to a significant reduction in inventory levels, bringing them closer to healthy standards [2]. - The average utilization rate in the LCD industry has been recovering since November 2024, maintaining above 80% in the first quarter of 2025. Adjustments will be made in the second quarter in response to changing demand [2][3]. LCD Product Pricing Trends - LCD TV panel prices for mainstream sizes have increased from January to March 2025 due to strong end-user demand. However, demand is expected to cool in the second quarter due to changes in the international trade environment and diminishing returns from "trade-in" policies [3]. - Prices for MNT panels in the IT sector are experiencing moderate increases, while NB panel prices remain stable [3]. Project Development - The company’s 8.6-generation AMOLED production line in Chengdu commenced equipment installation four months ahead of schedule on May 20, marking a transition from construction to operational phase, which is crucial for future product launches and mass production [4]. Depreciation and Capital Expenditure - The company anticipates depreciation of approximately 38 billion in 2024, with a peak expected this year as new projects become operational and existing production lines reach the end of their depreciation period [4][5]. - Future capital expenditures will focus on the "screen and IoT" strategy, emphasizing semiconductor display business and innovation in IoT, with investments directed towards new projects, outstanding payments for existing projects, and maintenance of current production lines [5].

Core Viewpoint - The major shareholders of Delong Laser (688170.SH) plan to reduce their holdings due to personal funding needs, with a total reduction of up to 3,100,800 shares, representing no more than 3% of the company's total share capital [1][2] Shareholder Reduction Plans - Beijing Woyan Investment Center and its concerted actors intend to reduce up to 3,100,800 shares, not exceeding 3% of the total share capital, through a combination of centralized bidding and block trading [1][2] - Shareholder Chen Jiang and his concerted actors plan to reduce up to 1,343,700 shares, not exceeding 1.30% of the total share capital, also through centralized bidding and block trading [1][2] Shareholding Structure - As of the announcement date, Beijing Woyan holds 10,026,837 shares (9.70% of total), while Jiangyin Woyan holds 1,583,163 shares (1.53%), Wuxi Yuyuan holds 410,000 shares (0.40%), and Suzhou Wojie holds 480,000 shares (0.46%), collectively holding 12,500,000 shares (12.09% of total) [2] - Tianlong Heavy Industry holds 1,180,000 shares (1.14%), and Chen Jiang holds 5,290,100 shares (5.12%), with a combined holding of 6,470,100 shares (6.26% of total) [2] Market Conditions and Uncertainties - The reduction period will occur within three months after the announcement, starting 15 trading days later, with uncertainties regarding the quantity, timing, and pricing of the share reductions [3] Company Financials - Delong Laser was listed on the Sci-Tech Innovation Board on April 29, 2022, with an initial offering price of 30.18 yuan per share, and has been in a state of decline since then [3] - The company raised a total of 780 million yuan, with a net amount of 714 million yuan, exceeding the original plan by 264 million yuan, intended for various expansion and development projects [3][4] - In 2024, the company reported revenue of 715 million yuan, a year-on-year increase of 22.93%, but a net loss of 34.5 million yuan compared to a profit of 39.05 million yuan in the previous year [5][6]

Core Viewpoint - The vaccine industry is expected to see a recovery in sales growth trends for key vaccine varieties in 2025, driven by a low base effect, which will improve company performance [1] Industry Summary - In Q1 2025, the overall number of vaccine batch approvals was 697, representing a year-on-year decline of 14% [1] - Significant year-on-year growth was observed in flu vaccines, DTP vaccines, and hepatitis vaccines, while polio vaccines, shingles vaccines, rotavirus vaccines, and HPV vaccines experienced notable declines [1] - The development of therapeutic vaccines for cancer is emerging as a hot area for vaccine indication expansion, with domestic research still in its early stages [1] - The competitive landscape for traditional key vaccine pipelines is intensifying, with many domestic companies entering the market [1] Company Summary - It is anticipated that key vaccine varieties will recover in sales growth in 2025, which will positively impact company performance [1] - Continuous advancement in innovative vaccine pipelines is expected to provide companies with greater market opportunities and potential for international expansion in the future [1]

Group 1 - Multiple securities firms are holding mid-term strategy meetings to discuss investment opportunities in the context of global changes, particularly focusing on China's prospects [1][3][10] - The mid-term strategy meetings are seen as a way for securities firms to enhance investor education and promote high-quality development in the capital market [4][5] - The meetings are expected to attract significant investor attention, as they often highlight new capital opportunities [7][10] Group 2 - Securities firms are optimistic about the equity market opportunities in the second half of 2025, with strategies focusing on domestic consumption, technology, and structural opportunities abroad [6][10] - Analysts predict that the A-share market will benefit from the restructuring of international order, with expectations of a stable index and structural bull market [6][10] - The upcoming strategy meetings will also address the impact of external uncertainties and the need for fiscal policies to boost domestic demand [7][10] Group 3 - The mid-term strategy meetings are being held in various formats, including online live broadcasts, to reach a broader audience, particularly younger and tech-savvy investors [5][6] - Major securities firms have scheduled additional strategy meetings for late May and June, indicating a trend of increased engagement with investors [8][9] - The discussions will also cover the implications of geopolitical dynamics on the capital market, with a focus on the comparative advantages of Chinese assets [10]

Core Insights - The main contract for the CSI 300 Index futures closed at 2506 with a slight increase of 0.43% as of May 21, with a trading volume of 56,300 contracts and a net short position of 14,821 contracts among the top 20 positions [1][3]. Trading Volume and Positions - Total trading volume for all CSI 300 Index futures contracts reached 77,800 contracts, an increase of 5,519 contracts from the previous day [1]. - Among the top 20 positions, long positions totaled 166,000 contracts, a decrease of 2,922 contracts, while short positions totaled 195,900 contracts, a decrease of 3,186 contracts [1][4]. Major Players - The top three long positions were held by Guotai Junan with a total of 38,726 contracts, CITIC Futures with 19,756 contracts, and Haitong Futures with 16,273 contracts [1][4]. - The top three short positions were held by CITIC Futures with 45,901 contracts, Guotai Junan with 26,612 contracts, and Haitong Futures with 18,588 contracts [1][4]. Changes in Positions - The top three increases in long positions were from Dongzheng Futures (8,036 contracts, +983), CITIC Futures (11,970 contracts, +302), and Zheshang Futures (2,533 contracts, +144) [1]. - The top three decreases in long positions were from Haitong Futures (14,080 contracts, -1,491), Guotai Junan (23,043 contracts, -1,432), and Guotai Futures (4,667 contracts, -419) [1]. - The top three increases in short positions were from Dongzheng Futures (9,154 contracts, +479), Galaxy Futures (3,341 contracts, +205), and Fangzheng Futures (1,680 contracts, +160) [1]. - The top three decreases in short positions were from CITIC Futures (31,187 contracts, -1,209), Haitong Futures (6,326 contracts, -387), and Everbright Futures (1,560 contracts, -271) [1].

Core Insights - The Shanghai Stock Exchange 50 Index futures contract closed at 2506 on May 21, with a slight increase of 0.46% and a trading volume of 27,200 contracts, indicating a decrease in trading activity compared to the previous day [1][3]. Trading Data Summary - Total trading volume for all contracts was 36,500 contracts, down by 754 contracts from the previous day [1][4]. - The top 20 positions showed a net short position with a difference of 5,753 contracts [1]. - Long positions in the top 20 decreased by 1,235 contracts to 50,800 contracts, while short positions decreased by 1,127 contracts to 61,600 contracts [1][4]. Major Players - The top three long positions were held by Guotai Junan with 8,465 contracts, CITIC Futures with 8,087 contracts, and Dongzheng Futures with 3,404 contracts [1][3]. - The top three short positions were held by Guotai Junan with 12,165 contracts, CITIC Futures with 8,633 contracts, and GF Futures with 6,432 contracts [1][3]. Position Changes - The top three increases in long positions were from Haitong Futures (+141 contracts), Zhongjin Wealth (+133 contracts), and招商期货 (+104 contracts) [1][3]. - The top three decreases in long positions were from Guotai Junan (-421 contracts), Guoxin Futures (-245 contracts), and Shenyin Wanguo (-180 contracts) [1][3]. - The top three increases in short positions were from CITIC Futures (+72 contracts), Zhongjin Futures (+55 contracts), and Guoxin Futures (+38 contracts) [1][3]. - The top three decreases in short positions were from Guotai Junan (-186 contracts), Dongzheng Futures (-192 contracts), and Guotai Junan (-197 contracts) [1][3].

持有公司股份60,298,577股，占公司当前总股本的12.5619%的股东张迎九计划在公告披露之日起15个交 易日后的3个月内，以集中竞价方式或大宗交易方式合计减持公司股份5,500,000股（占公司总股本比例 1.1458%，占剔除公司回购专用账户中股份后的总股本比例1.1467%）。 中国经济网北京5月21日讯 美畅股份（300861）（300861.SZ）昨晚披露关于公司持股5%以上股东减持 股份的预披露公告称，公司近日收到股东张迎九、贾海波分别出具的《股份减持告知函》。 持有公司股份29,368,272股，占公司当前总股本的6.1182%的股东贾海波计划在公告披露之日起15个交 易日后的3个月内，以集中竞价方式或大宗交易方式合计减持公司股份5,500,000股（占公司总股本比例 1.1458%，占剔除公司回购专用账户中股份后的总股本比例1.1467%）。 美畅股份表示，上述股东不是公司的控股股东、实际控制人，亦不是公司现任董事、监事和高级管理人 员。本次减持计划的实施不会对公司治理结构、持续经营产生重大影响，不会导致公司控制权发生变 更。 美畅股份发行费用总计103,303,438.09元，其中保荐 ...

头部券商的投行工作曾经是多少优秀学子梦寐以求的去向。不过，近两年，随着投行业务连续下滑，不 少投行人士纷纷改行，除了考公之外，入职上市公司当董秘也成为重要选项之一。 5月19日收盘后，科创板上市公司毕得医药（SH688073，股价42.11元，市值38.27亿元）发布公告称， 公司董事会同意聘任王轩担任公司董秘。 简历显示，王轩曾在中信建投投资银行部任职多年，任高级副总裁、保荐代表人（以下或简称保代）， 曾主持或参与多个投行项目。 《每日经济新闻》记者注意到，据统计，2024年以来，有24位新任A股上市公司董秘曾有保荐代表人资 格，其中不乏来自头部券商投行部门相关领导岗位的资深投行人士。2025年以来，业内保代总人数大幅 减少超过250人，保代人数此前多年持续上行的趋势或迎来拐点。 毕得医药原董秘3月离职 5月19日收盘后，科创板上市公司毕得医药发布公告称，经公司董事长提名，董事会提名委员会资格审 核，董事会同意聘任王轩女士担任公司董事会秘书职务。 简历显示，1985年出生的王轩具有较为丰富的资本市场工作经验，曾就职于中信建投投资银行部，任高 级副总裁、保荐代表人、内核委员。在此次出任毕得医药董秘之前，王轩自 ...